emetine has been researched along with Cancer of Ovary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (90.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iizumi, Y; Sakai, T; Sowa, Y; Sun, Q; Yogosawa, S | 1 |
| Collins, JL; Horuchi, T; Kao, MS; Powell, CB | 1 |
| Collins, JL; Manning, K; Powell, CB | 1 |
| Adler, LM; Herzog, TJ; Kost, ER; Mutch, DG; Williams, S | 1 |
| Collins, JL; Powell, CB; Scott, JH | 1 |
| Collins, JL; Mutch, DG; Williams, S; Xu, L | 1 |
| Chen, CA; Collins, JL; Herzog, TJ; Mutch, DG | 1 |
| Collins, JL; Kao, MS; Mutch, DG; Powell, CB | 1 |
| Collins, JL; Kao, MS; Massad, LS; Mutch, DG; Powell, CB | 2 |
10 other study(ies) available for emetine and Cancer of Ovary
| Article | Year |
|---|---|
The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Cisplatin; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Emetine; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Tumor Cells, Cultured | 2015 |
Interferon alfa activates a lytic mechanism in ovarian and cervical carcinoma cells.
Topics: Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Emetine; Female; Humans; Interferon-alpha; Ovarian Neoplasms; Protein Biosynthesis; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1993 |
Interferon-alpha (IFN alpha) induces a cytolytic mechanism in ovarian carcinoma cells through a protein kinase C-dependent pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Analysis of Variance; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Emetine; Female; Humans; Interferon alpha-2; Interferon-alpha; Isoquinolines; Ovarian Neoplasms; Piperazines; Protein Biosynthesis; Protein Kinase C; Recombinant Proteins; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
The role of tumor necrosis factor receptors in tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Binding, Competitive; Cross-Linking Reagents; Emetine; Female; Humans; Iodine Radioisotopes; Ovarian Neoplasms; Protein Synthesis Inhibitors; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
Topics: Animals; Antineoplastic Agents; Dactinomycin; Emetine; Female; Humans; Lymphotoxin-alpha; Mice; Ovarian Neoplasms; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1998 |
Divergent effects of taxol on tumor necrosis factor-alpha-mediated cytolysis of ovarian carcinoma cells.
Topics: Carcinoma; Cytotoxins; Drug Synergism; Emetine; Female; Humans; Ovarian Neoplasms; Paclitaxel; Protein Biosynthesis; Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Death; Cisplatin; Cycloheximide; Cyclosporine; Doxorubicin; Drug Interactions; Drug Resistance; Emetine; Female; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1992 |
Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
Topics: Animals; Arachidonic Acid; Cell Line; Cell Survival; Drug Resistance; Emetine; Female; Humans; Mice; Neoplasm Proteins; Ovarian Neoplasms; Phospholipases A; Phospholipases A2; Quinacrine; Recombinant Proteins; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1992 |
Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies.
Topics: Cell Line; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Emetine; Female; Genital Neoplasms, Female; Humans; Interferon-gamma; Ovarian Neoplasms; Protein Biosynthesis; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1991 |
Expression of a resistance mechanism in ovarian and cervical carcinoma cells prevents their lysis by gamma-interferon.
Topics: Cell Line; Cell Survival; Dactinomycin; Drug Resistance; Emetine; Female; Humans; Interferon-gamma; Kinetics; Ovarian Neoplasms; Recombinant Proteins; Time Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1990 |